EPIX insider transaction filings
ESSA Pharma Inc. — 9 most recent Form 4 filings from SEC EDGAR, normalized by FilingPulse. Latest filing: 2025-10-15. Screen EPIX transaction legs live →
| Filed | Form | Insider | Reported transactions | Source |
|---|---|---|---|---|
| 2025-10-15 | 4 | Wood David S. — Chief Financial Officer | Disposition to issuer (D): 33,343 | EDGAR |
| 2025-10-15 | 4 | Requadt Scott — Director | Disposition to issuer (D): 30,002 | EDGAR |
| 2025-10-15 | 4 | Thorell Marella — Director | Disposition to issuer (D): 2,881 | EDGAR |
| 2025-10-15 | 4 | Martin John Alexander — Director | Disposition to issuer (D): 14,299 | EDGAR |
| 2025-10-15 | 4 | Parkinson David Ross — President and CEO, Director | Disposition to issuer (D): 65,675 | EDGAR |
| 2025-10-15 | 4 | Glickman Richard M — Director | Disposition to issuer (D): 43,240 | EDGAR |
| 2025-10-15 | 4 | BERGER FRANKLIN M — Director | Disposition to issuer (D): 784,404 | EDGAR |
| 2025-10-14 | 4 | BVF PARTNERS L P/IL — 10% owner BIOTECHNOLOGY VALUE FUND L P — 10% owner BVF I GP LLC — 10% owner BIOTECHNOLOGY VALUE FUND II LP BVF II GP LLC Biotechnology Value Trading Fund OS LP BVF Partners OS Ltd. BVF GP HOLDINGS LLC — 10% owner BVF INC/IL — 10% owner LAMPERT MARK N — 10% owner | Code (U): 6,194,145 · Code (U): 4,726,743 · Code (U): 560,797 | EDGAR |
| 2025-08-07 | 4 | BVF PARTNERS L P/IL — 10% owner BIOTECHNOLOGY VALUE FUND L P — 10% owner BVF I GP LLC — 10% owner BIOTECHNOLOGY VALUE FUND II LP BVF II GP LLC Biotechnology Value Trading Fund OS LP BVF Partners OS Ltd. BVF GP HOLDINGS LLC — 10% owner BVF INC/IL — 10% owner LAMPERT MARK N — 10% owner | Option exercise/expiry (X): 1,481,634 @ $0.00 · Option exercise/expiry (X): 1,235,030 @ $0.00 · Option exercise/expiry (X): 203,336 @ $0.00 · Sale (S): 79 @ $1.88 · Sale (S): 66 @ $1.88 · Sale (S): 11 @ $1.88 · +3 more | EDGAR |
Recent 8-K events — ESSA Pharma Inc.
| Filed | Form | Items reported | Source |
|---|---|---|---|
| 2025-10-09 | 8-K | 2.01 — Completion of Acquisition or Disposition of Assets 3.01 — Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing 3.03 — Material Modification to Rights of Security Holders 5.01 — Changes in Control of Registrant 5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers 8.01 — Other Events 9.01 — Financial Statements and Exhibits | EDGAR |
| 2025-10-06 | 8-K | 5.07 — Submission of Matters to a Vote of Security Holders 8.01 — Other Events 9.01 — Financial Statements and Exhibits | EDGAR |
| 2025-10-03 | 8-K | 8.01 — Other Events | EDGAR |
| 2025-09-30 | 8-K | 8.01 — Other Events 9.01 — Financial Statements and Exhibits | EDGAR |
| 2025-09-24 | 8-K | 1.01 — Entry into a Material Definitive Agreement 8.01 — Other Events 9.01 — Financial Statements and Exhibits | EDGAR |
| 2025-09-10 | 8-K | 8.01 — Other Events 9.01 — Financial Statements and Exhibits | EDGAR |
| 2025-08-25 | 8-K | 8.01 — Other Events 9.01 — Financial Statements and Exhibits | EDGAR |
| 2025-08-14 | 8-K | 8.01 — Other Events 9.01 — Financial Statements and Exhibits | EDGAR |
| 2025-08-06 | 8-K | 8.01 — Other Events 9.01 — Financial Statements and Exhibits | EDGAR |
| 2025-07-31 | 8-K | 8.01 — Other Events 9.01 — Financial Statements and Exhibits | EDGAR |
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?ticker=EPIX returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new ones to you in seconds. API docs →